Agoracom Blog Home

Posts Tagged ‘small cap’

« Older Entries
Newer Entries »

Empower Clinics $CBDT.ca – #Marijuana Survey Shows #Boomers Embracing #Cannabis & #CBD According to Aging Expert, Lisa Cini $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 6:15 PM on Monday, March 16th, 2020

SPONSOR:

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics.
  • Patient database of over 165,000 patients 
  • Platform generating $1.4M USD (9 months ending Sept. 30, 2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Recently launched CBD extraction facility
  • First extraction system capacity = 2,300 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025
  • Company to Create Psilocybin and Psychadelics Division Leveraging Corporate Wellness Clinics and Franchise Clinic Network

Marijuana Survey Shows Boomers Embracing Cannabis & CBD According to Aging Expert, Lisa Cini

COLUMBUS, Ohio -With 9 in 10 Americans favoring legalization of Marijuana for recreation or medicinal purposes and New York weeks away from a decision, aging expert Lisa Cini shares details of marijuana and cannabidiol (CBD) usage among the 11,000+ boomers who responded to her marijuana survey and answered a variety of questions on marijuana consumption, opinion, and usage.

“It’s time to mainstream senior-friendly tools for using marijuana, and consider implications for designing seniors’ living spaces, or help those marijuana-using seniors living in multi-generational homes to partake in designated ways and areas as not to offend family members who don’t use, including children and grandchildren.”Tweet this

“I’m not surprised that 83% of the respondents are using some form of cannabis for recreational and medical reasons. 66% partake daily and believe that marijuana and/or CBD use is an important component of their lives,” says Lisa Cini, senior living expert and author of BOOM: The Baby Boomers Guide to Leveraging Technology, so that you can Preserve Your Independent Lifestyle & Thrive. “Don’t forget that much of the boomer generation grew up smoking weed. Some never stopped, resumed in retirement, or when they were no longer raising children. Because the aging process is unforgiving as it relates to pain, seniors are finding relief from achy bones and joints, arthritis, sleeplessness, and many other ailments, proving that there’s a great deal more to marijuana than just getting high, especially for those battling health and comfort challenges.”

Seniors are using weed in any number of ways, from smoking to baking and preparing full meals with cannabutter for many perceived health benefits including relief from insomnia, anxiety, chronic pain, depression, muscle tension, arthritis, and migraines in addition to getting high.

For those who desire CBD without THC, popular brands like vitafusion™ now offer gummy vitamins with full spectrum hemp extract and natural phytocannabinoids (225mg & 10mg CBD per gummy), Blissful Sleep with 5mg Melatonin (300mg with 10mg CBD per gummy) to induce sleep, and Chillaxed Mood with natural phytocannabinoids & 10mg L-Theanine (300 mg & 10mg CBD per gummy) to promote calm mental alertness, in contrast to the restless energy sometimes produced by caffeine. CBD creams and other skin care products are touted for anti-aging and appeal to boomers. CBD Anti-Aging Cream with Apple Stem Cells, was voted #1 Best Anti-Aging CBD Skin Cream in 2019 and for those with sensitive skin, Abinoid Botanicals Face Serum – Blue Chamomile & Hemp was voted #2 best hemp cream.

“Marijuana and CBD use is a reality that can no longer be ignored, as it’s very much a part of the daily lives of so many,” adds Cini. “It’s time to mainstream senior-friendly tools for using marijuana, and consider implications for designing seniors’ living spaces, or help those marijuana-using seniors living in multi-generational homes to partake in designated ways and areas as not to offend family members who don’t use, including children and grandchildren.”

Lisa Cini is an award-winning senior living designer, President / CEO, Mosaic Design Studio and author of BOOM: The Baby Boomers Guide to Leveraging Technology, so that you can Preserve Your Independent Lifestyle & Thrive, The Future is Here: Senior Living Re-imagined, and Hive, which describes her family’s four generations living under the same roof in her own home. Go to Lisamcini.com to sign up for her blog. If you want to find the best tech products that help seniors Embrace Aging and Live Independently, visit BestLivingTech.com.

Source: https://www.businesswire.com/news/home/20200309005150/en/Marijuana-Survey-Shows-Boomers-Embracing-Cannabis-CBD

Tags: , , , ,
Posted in All Recent Posts, Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca – #Marijuana Survey Shows #Boomers Embracing #Cannabis & #CBD According to Aging Expert, Lisa Cini $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Empower Clinics $CBDT.ca – #Cannabis Won’t Cure #Coronavirus, but It Can Help Ease Certain Flu Symptoms $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 5:00 PM on Friday, March 13th, 2020

SPONSOR:

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics.
  • Patient database of over 165,000 patients 
  • Platform generating $1.4M USD (9 months ending Sept. 30, 2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Recently launched CBD extraction facility
  • First extraction system capacity = 2,300 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025
  • Company to Create Psilocybin and Psychadelics Division Leveraging Corporate Wellness Clinics and Franchise Clinic Network

Cannabis Won’t Cure Coronavirus, but It Can Help Ease Certain Flu Symptoms

By Brianna Wheeler |

During a normal flu season, frequent weed smokers know the drill.

Pay closer attention to everyone’s cough patterns during a smoke sesh. Stop accepting mouth-wet blunts from strangers. And if you think you’re coming down with something, wave a lighter under the mouthpiece before passing the pipe.

This year, obviously, things are a bit more serious. We’re dealing with multiple citywide quarantines, global economic disruption, and a pandemic being compared to the damn Spanish flu. It’s enough to make self-respecting cannabis enthusiasts re-evaluate their medicine cabinet and diversify their stash box.

Obviously, there’s no dependable research on CBD’s or THC’s effect on COVID-19. But we do know a few things about cannabis and general wellness. Down the rabbit hole of alternative cannabinoids and non-psychoactive cannabis, there is a wealth of potential medicinal benefits both preventative and curative.

At least when it comes to the regular flu, CBD has been found to help support immune systems, ease symptoms, and replace over-the-counter pain relievers, sleep aids, and medicated salves currently taking up space in our medicine cabinet. But not just any CBD will do, and CBD alone won’t do it all.

Obviously, the best course of action right now is to keep vigorously washing your hands, mind your coughs, avoid large crowds, and be a bit more stingy with your pipes and joints. But if you find yourself slipping under the weather, for whatever reason, here are a few things to know about how cannabis might help ease symptoms.

CBD for Immune System Support

Tons more research is required to accurately map the relationship between the immune and endocannabinoid systems, but it’s well established that CBD helps reduce self-harming autoimmune and inflammatory responses. “CBD has been found to act as an immune system modulator,” says Anna Symonds, director of East Fork Cultivars’ CBD Certified program. “This means that it’s like a thermostat—it can turn the level of activity down or up, depending on the body’s needs.”

Source: https://www.wweek.com/potlander/2020/03/10/cannabis-wont-cure-coronavirus-but-it-can-help-ease-certain-flu-symptoms/

Tags: , , , , ,
Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca – #Cannabis Won’t Cure #Coronavirus, but It Can Help Ease Certain Flu Symptoms $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Empower Clinics $CBDT.ca Announces Advancement of Joint Venture with Heritage Cannabis in the United States $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 8:24 AM on Thursday, March 5th, 2020
  • Announced the advancement of its previously announced Joint Venture Partnership with Heritage Cannabis Holdings Corp. (CSE: CANN), based in Sandy, Oregon, USA.
  • Now advancing the JV with the order and installation of extraction and post-production equipment units at Empower’s existing licenced hemp processing facility in Sandy, Oregon,
  • Will immediately begin performing hemp-based product manufacturing for proprietary formulations, tolling services, and third-party white labelling services for other distributors throughout the United States

VANCOUVER, BC / March 5, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (OTC:EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented life sciences company is pleased to announce the advancement of its previously announced Joint Venture Partnership (“JV”) with Heritage Cannabis Holdings Corp. (CSE: CANN) (“Heritage”), based in Sandy, Oregon, USA.

In September 2019, Empower announced it had entered into a Letter of Intent (“LOI”) to form a 50/50 ownership JV with Heritage for the extraction of hemp for CBD oil production, and formulated CBD products. The JV is equally funded by both parties and since formation CDN$250,000 has been provided to the JV.

Heritage and Empower are now advancing the JV with the order and installation of extraction and post-production equipment units at Empower’s existing licenced hemp processing facility in Sandy, Oregon, in order to immediately begin performing hemp-based product manufacturing for proprietary formulations, tolling services, and third-party white labelling services for other distributors throughout the United States.

The proprietary branded products will be distributed through Empower’s corporately owned physician staffed health clinics in Oregon and Arizona, online at www.sunvalleyhealth.com and in upcoming new franchise locations, which currently have access to over 165,000 patients.

Additionally, related downstream equipment is now being installed including gel cap processing, tincture bottle and vape cartridge filling, as well as labelling, packaging, storage and shipping services, to offer full-service end-to-end products to third parties.

Heritage is providing training and supervision related to the proprietary methods of extraction and oil production that is already being successfully produced in Canada by Heritage.

“Having the backing of an experienced partner with the financial strength of Heritage Cannabis is proving to be so beneficial for the development of our first extraction facility”, said Steven McAuley, Chief Executive Officer of Empower. “Together, we have already identified numerous opportunities to bring new orders to the JV facility, ensuring we leverage the capacity we are building.”

“We are very pleased to be advancing our U.S. strategy through this mutually beneficial partnership with Empower, which provides Heritage ease of access to the world’s largest cannabis market”, stated Clint Sharples, Chief Executive Officer of Heritage. “The installation of extraction units is the next phase of the JV and another step toward successfully furthering our growth strategies.”

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

About Heritage Cannabis Holdings Corp.

The Company is focused on becoming a vertically integrated cannabis provider that currently has two Health Canada approved licenced producers, through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp. both regulated under the Cannabis Act Regulations. Working under these two licences, Heritage has two additional subsidiaries, Purefarma Solutions, which provides extraction services, and a Medical Services Division which is focused on cannabis based medical solutions. Heritage as the parent company, is focused on providing the resources for its subsidiaries to advance their products or services to compete both domestically and internationally.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley
CEO
[email protected]
604-789-2146

Investors: Dustin Klein
SVP, Business Development
[email protected]
720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Tags: , , , , ,
Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca Announces Advancement of Joint Venture with Heritage Cannabis in the United States $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Empower Clinics $CBDT.ca Announces Significant Patient Growth in February 2020 with Visits Increasing by 800% $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 7:02 AM on Wednesday, March 4th, 2020
  • Patient visits in corporate clinics increased by 800% in February 2020 versus the same period in 2019
  • Total patient visits of 1,817 in February 2020 compared to 227 in February 2019

VANCOUVER, BC / March 4, 2020 / EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented life sciences company, is pleased to announce that patient visits in corporate clinics increased by 800% in February 2020 versus the same period in 2019, with total patient visits of 1,817 in February 2020 compared to 227 in February 2019.

“Patient volumes have remained strong to start the year in all clinics, continuing on our push for a record first quarter.” said Dustin Klein, SVP Business Development and Director of Empower. “Operational excellence each day, combined with exemplary care for the patient, sets us apart in the markets we serve.”

The Company also has received numerous inquiries with both positive and supportive sentiment, after the recent announcement of the Company’s intention to create a psilocybin and psychedelics division.

“Getting positive reinforcement from researchers, physicians, advocates and practitioners about our intention to enter this developing field of study, gives me confidence that we have made the correct decision to leverage our corporate assets for psilocybin and psychedelics research and development.” said Steven McAuley, Chairman & CEO of Empower.

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley

CEO

[email protected]

604-789-2146

Investors: Dustin Klein
SVP, Business Development
[email protected]
720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE: Empower Clinics Inc.

Tags: , , , , ,
Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca Announces Significant Patient Growth in February 2020 with Visits Increasing by 800% $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Empower Clinics $CBDT.ca – CBD consumption to rise across the treatment of neurological conditions $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 1:53 PM on Thursday, February 27th, 2020

SPONSOR:

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics.
  • Patient database of over 165,000 patients 
  • Platform generating $1.4M USD (9 months ending Sept. 30, 2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Recently launched CBD extraction facility
  • First extraction system capacity = 2,300 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025
  • Company to Create Psilocybin and Psychadelics Division Leveraging Corporate Wellness Clinics and Franchise Clinic Network

CBD consumption to rise across the treatment of neurological conditions

Research shows that CBD consumption for the treatment of neurological conditions is set to rise.

  • With an exponential rise in the availability of CBD products and public opinion towards it becoming more positive over the past decade, the consumption of the ingredient has exploded.
  • Global Market Insights, Inc., forecasts that global cannabidiol market size will be worth more than $89bn by 2026.

By: Health Europa

However, the industry will need to overcome the complex regulatory landscape as well as quality and supply challenges in the near future.

Over the past few years, cannabidiol, or CBD, has caught the public’s imagination as an ingredient presenting a range of health benefits when infused in various consumables. More and more individuals worldwide are now vouching for its effectiveness in terms of alleviating certain chronic illnesses and treating several health conditions.

CBD has conquered industry after industry, from pharmaceuticals to personal care and cosmetics, food and beverages, and nutraceuticals.

Cannabidiol is the legal and non-psychoactive counterpart of tetrahydro cannabidiol (THC), the chemical compound responsible for cannabis’s psychological effects. CBD is the second most-commonly used active ingredients of cannabis. The cannabinoid is derived directly from the hemp plant, a cousin of the cannabis plant, and forms an essential component of medical cannabis.

CBD regulatory landscape in Europe

Factors such as population growth, nationalised healthcare, GDP, and cultural historic use of CBD in many European countries make the continent an attractive market for global producers of both medical and retail cannabis-based products. Hemp cultivation in the region has witnessed a massive upsurge in recent years; the European Union (EU) constitutes more than 25% of the global hemp production.

In July last year Epidiolex CBD oil received a positive recommendation for marketing approval from the European Medicines Agency (EMA) for the treatment of seizures. EMA’s Human Medicines Committee (CHMP) approved the oral solution for use with clobazam for the treatment of seizures associated with Dravet syndrome or Lennox-Gastaut syndrome in patients aged two or more.

The European Commission granted marketing approval to Epidyolex, the trade name for Epidiolex in Europe, in September 2019. Epidiolex is the only federally-approved CBD product in the U.S.

Additionally, the use of CBD in cosmetics is harmonised within the European Cosmetic Regulation 1223/2009. The regulation prohibits the use of cannabis and its derivatives in cosmetic products. Essentially, EU prohibits the use of CBD derived naturally from cannabis plants. However, the use of hemp-derived or synthetically-produced cannabidiol is approved.

Europe CBD market is poised to witness monumental growth in the forthcoming years on account of surging consumer demand for safe-strength CBD products that are easily available in their normal retail environments and cultivated, extracted, processed and labelled as per the European standards.

Growing burden of neurological diseases in Europe

Europe has witnessed a growing occurrence of various neurological conditions in recent years. These include epilepsy, migraine, stress, anxiety, and numerous sleeping disorders. An expanding geriatric population base indicates rising incidences of these conditions. Citing data from the European Brain Council, more than 220 million people in Europe suffer from at least one neurological condition, which is more than the populations of France, Germany, and the Great Britain combined.

Described below are some of the most prevalent neurological conditions in Europe and the effectiveness of CBD in their treatment.

  • Stress and anxiety – Nearly 25% of the European population suffers from stress, anxiety or depression each year. The effectiveness of CBD products as anti-anxiety nutraceuticals is backed with plenty of research, however there is still a long way to go. Several clinical trials have provided considerable evidence of cannabidiol’s usefulness for the treatment of generalised anxiety disorder (GAD), post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), social anxiety disorder, and panic disorder;
  • Migraine – Migraine currently affects more than 11% of the global population. The social societal burden of migraine in Europe is an approximately €27bn per year. While pain medications are known to help temporarily alleviate the symptoms of migraine, they can have several side-effects. Research concerning the use of cannabidiol for migraine is limited however a number of laboratory studies suggest that CBD oil may help reduce all types of acute and chronic pain, including migraine; and
  • Seizures – In Europe, close to six. million people suffer from epilepsy, while 15 million people will have at least one seizure at some point during their lifetime. Numerous research studies over the years have demonstrated the benefits and effectiveness of hemp-derived CBD products in patients with epilepsy who have not responded to traditional treatment.

Surging popularity of cannabidiol among boomers along with ongoing research and development into its potential health benefits will augment CBD market forecast. More and more boomers are adding CBD to their health regimes to help reduce stress and anxiety, get better sleep, and alleviate chronic pain. Increasing awareness towards the safety and efficacy of cannabidiol products will drive future CBD industry trends.

Source: https://www.healtheuropa.eu/cbd-consumption-to-rise-across-the-treatment-of-neurological-conditions/98105/

Tags: , , , , , ,
Posted in All Recent Posts, Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca – CBD consumption to rise across the treatment of neurological conditions $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Empower Clinics $CBDT.ca – CBD Sales Predicted to Grow, #cannabis and #cannabidiol #CBD products reached $14 billion in 2019 $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 12:05 PM on Wednesday, February 26th, 2020

SPONSOR:

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics.
  • Patient database of over 165,000 patients 
  • Platform generating $1.4M USD (9 months ending Sept. 30, 2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Recently launched CBD extraction facility
  • First extraction system capacity = 2,300 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025
  • Company to Create Psilocybin and Psychadelics Division Leveraging Corporate Wellness Clinics and Franchise Clinic Network

CBD Sales Predicted to Grow, Market Analysis Finds

  • U.S. retail sales of cannabis and cannabidiol (CBD) products reached $14 billion in 2019
  • On pace to increase 18% per year to $33 billion in 2024

By WholeFoods Magazine Staff

Rockville, MD—U.S. retail sales of cannabis and cannabidiol (CBD) products reached $14 billion in 2019, and are on pace to increase 18% per year to $33 billion in 2024, according to data published in a new report from Packaged Facts titled Cannabis and CBD: U.S. Retail Market Trends and Opportunities.

The most common delivery format for cannabis, the flower—smoked as buds or as cigarettes—accounts for nearly 40% of retail sales, according to a press release. Vaporizer cartridges with concentrated THC or CBD compounds takes the second largest share, but it’s falling, as concerns about vaping-related lung illnesses rise. Edibles and topicals are predicted to rise, and to rise quickly, as they stand to benefit the most from legalization of hemp-based CBD; major retailers are already offering CBD-infused food and beverages, as well as CBD-infused cosmetics.

The report analyzes cannabis and cannabis-related retail trends and opportunities in the U.S., with a focus on multi-state cannabis dispensary operators and food and beverage introductions, as well as market trends by state. It also includes a detailed analysis of cannabis-related legal and regulatory trends at the federal and state levels. The report can be purchased here.

Source: https://wholefoodsmagazine.com/suppliers/news-suppliers/cbd-sales-predicted-to-grow-market-analysis-finds/

Tags: , , , , , , ,
Posted in All Recent Posts, Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca – CBD Sales Predicted to Grow, #cannabis and #cannabidiol #CBD products reached $14 billion in 2019 $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

St-Georges Eco-Mining Corp. $SX $SX.ca $SXOOF Provides Winter Corporate Update

Posted by AGORACOM-JC at 3:41 PM on Monday, February 10th, 2020

Highlights

  • Lithium Processing: technology initiatives, patent formalization, battery recycling process and lithium metal manufacturing;
  • Pilot plant potentially de-risked through discussions with ready-built facilities;

Montreal, Montreal -  February 10, 2020 – St-Georges Eco-Mining Corp. (CSE:SX) (CNSX:SX.CN) (OTC:SXOOF) (FSE:85G1) would like to update its shareholders on its on-going corporate developments.

In the past six months, St-Georges has successfully executed its strategy to strengthen and expand its focus on its green extraction metallurgical processes development and re-center its exploration efforts on energy metals in Quebec and Iceland. The team has also added a Palladium-Rhodium project in Quebec and has advanced its Thor Gold Project in Iceland to drill-ready status. Significant changes in the Company operations, namely the sale of King of the North in September and the spin-off of ZeU Crypto Networks Inc. in December, has allowed the Company to free up resources that can now be allocated to the core competencies of the Company.

Highlights

– Lithium Processing: technology initiatives, patent formalization, battery recycling process and lithium metal manufacturing;

– Pilot plant potentially de-risked through discussions with ready-built facilities;

– Julie Nickel developments;

– Iceland Resources EHF/St-Georges Iceland ltd update;

– Borealis Derivative Exchange EHF status update;

– Hydro-Dam Project in Iceland advancing on its environmental permits;

– Status of Other Holdings.

Mineral Processing Research & Development

Lithium Processing Technology

Stage I of the development of the Company’s lithium processing technology, in collaboration with Iconic Minerals (TSX-V: ICM), was completed in the first half of 2019 (See July 24, 2019 Press Release). Following the delivery of the Stage I independent report to ICM, St-Georges has accelerated the work and obtained results on many tasks that are part of Stage II and Stage III of the planned development.

On-going testing has confirmed, so far, the portability of the process developed for sediments to hard rock sources of lithium. 

The Company is looking at opportunities to apply its technologies to other advanced mining projects, in particular, ones that currently produce spodumene concentrate, but have not yet decided to build an expensive tech plant for refining. Potential adopters of the technology have been identified, and discussions initiated. In addition, the Company is looking at the potential to retrofit existing facilities. Management will update the public on the status of these discussions when materiality requires it.

St-Georges filed the final documentation with the US Patent Office allowing its patent application to move from its provisional status to the formal patent application stage. The Company also filed a PCT application for the same patent potentially giving it protection in an additional 152 countries. The final version of the patent application now allows for the recovery of lithium from recycled batteries. St-Georges intends to position itself as an ideal partner to provide strategic materials to the battery industry, which includes recycling and recovery of the new generation of batteries, including solid-state batteries. Additionally, this patent application covers recycling as well as lithium metal and alloys manufacturing.

Pilot Plant(s)

St-Georges’ management and the metallurgical team have worked on the design, the sourcing of equipment, and the financial aspects of its proposed pilot plant for the better part of the last six months. In an effort to lower the risk of the proposal, the team has initiated discussions with ready-built facilities with extra capacity. This could allow St-Georges to build its pilot plant’s processing circuit faster with only minor modifications to the ready-built facilities. Early estimates confirm that capital expenditure should only be a fraction of the original budgeted cost as the Company will be leasing the facilities long-term. The Company expects to have secured an agreement for the pilot plant facilities in Q2 2020. 

Mineral Exploration

Julie Nickel Project

Following last year’s fieldwork, the Company’s geological team and exploration sub-contractors are planning additional drilling on the Julie Nickel property. The exploration plan for the coming years will be presented to the local stakeholders and First Nations in Q1, and the updated permitting request should be filed by Q2 for work in early summer. Additional bulk sampling should be performed to advance a nickel-iron initiative by the Company’s metallurgical team.

Preliminary discussions are on-going with a ferronickel consortium planning a project in Quebec.

Manicouagan Palladium-Rhodium Project

Much like the Julie Project, the Manicouagan Project has nickel and copper that meets the conventional concentrates requirements based on the type of sulphates it contains. Additionally, the recrystallized nature of this region lends itself to higher recoveries of each crystal form and better conversion.

The presence of well-known high-grade Palladium-Rhodium-Ruthenium surface showings (See January 27, 2020, Press Release), regardless of size, allows St-Georges to significantly reduce its costs to acquire PGE concentrate material for metallurgical bench testing of its processing and refining metallurgical process for Palladium-Rhodium-Ruthenium. 

St-Georges exploration team is planning a pre-drilling surface campaign to obtain permitting to intervene on-site in mid-summer. At the same time, St-Georges’ management is having early-stage discussions with potential farm-in or earn-in partners to advance the project at a faster pace.

Borealis EHF

The hybrid decentralized and distributed ledger-driven derivative trading platform is coming together at a good pace. Regulatory discussions are now in control of the timeline for the delivery of the platform.

Islensk Vatnsorka Hf – Iceland Hydro-Electric Dam Project

Islensk informed the Company that the permitting process is moving within the expected timeline and according to expectations. The Company still believes that the project will be fully permitted by the end of 2020. 

Iceland Resources EHF/St-Georges Iceland ltd

On August 21, 2019, the Icelandic authorities approved St-Georges’ previously disclosed work program for the coming year (See March 2, 2019 Press Release). The core projects have seen a fair share of exploration work, while some secondary projects have been repeatedly delayed due to extreme weather conditions in northern and eastern Iceland.

Work on the Thor Gold Project has brought it to drill-ready status. Surface rights and environmental conditions are no longer problematic, and the Company has requested a legal opinion to confirm that it can drill on the sole basis of its central government license.

The Company did, however, take samples at Thor during the winter season that are currently being analyzed. The Company is now preparing a bulk sample program at Thor. The material will be sent to be processed in Canada as soon as the weather allows it sometime in Q2.

The Company is currently in discussions to acquire the balance of the surface rights that escape its ownership on the project and is looking to acquire the last portion equity own by a third party in the Thor Gold Project.

Status of other holdings

The Company currently holds the following assets as of January 31, 2020.

Vilhjalmur Thor Vilhjalmsson, President and CEO of St-Georges, commented: “(…) the last six months have been for the Company both challenging but exciting. With the successful listing of ZeU Crypto Networks Inc., the sale of KOTN, funding above market prices, and now faster-than-expected progress in regards to the pilot plant, the team has shown its capabilities to deliver.”

___________________________________________________________________________

ON BEHALF OF THE BOARD OF DIRECTORS

“Vilhjalmur T. Vilhjalmsson”

VILHJALMUR THOR VILHJALMSSON, PRESIDENT & CEO

About St-Georges 

St-Georges is developing new technologies to solve some of the most common environmental problems in the mining industry. The Company controls directly or indirectly, through rights of first refusal, all the active mineral tenures in Iceland. It also explores for nickel-copper-cobalt and Palladium-Palladium-Rhodium-Ruthenium on the Julie Nickel Project & the Manicouagan Palladium-Rhodium Project on the Quebec’s North Shore. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1.

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

Tags: , , , , ,
Posted in St Georges Eco-Mining Technologies | Comments Off on St-Georges Eco-Mining Corp. $SX $SX.ca $SXOOF Provides Winter Corporate Update

New trading platform aims to unlock investment in #renewables, big #batteries SPONSOR: $HPQ.ca Silicon $FSLR $SPWR $CSIQ $PYR.ca $XMG.ca

Posted by AGORACOM-JC at 10:45 AM on Monday, February 3rd, 2020

SPONSOR: HPQ-Silicon Resources HPQ: TSX-V aiming to become the lowest cost producer of Silicon Metal and a vertically integrated and diversified High Purity, Solar Grade Silicon Metal producer. Click here for more info.

New trading platform aims to unlock investment in renewables, big batteries

  • A digital energy trading platform that paves the way for clean energy technologies, including “big batteries”, to participate directly and optimally in the wholesale electricity market is set to be launched with the backing of the Australian Renewable Energy Agency

By: Sophie Vorrath

A digital energy trading platform that paves the way for clean energy technologies, including “big batteries”, to participate directly and optimally in the wholesale electricity market is set to be launched with the backing of the Australian Renewable Energy Agency.

The first of its kind online market platform called the Renewable Energy Hub creates power purchasing deals customised to new energy technologies, including grid-scale battery storage systems, rather than outdated contract templates designed around coal and gas plants.

Renewable Energy Hub’s head of markets Chris Halliwell said the traditional market used by generators and retailers to hedge against huge fluctuations in wholesale electricity prices worked to effectively shut out new technologies by presuming an ability to provide “baseload” generation.

He says the Hub, which claims to have so far contracted more than 2GWh of renewable electricity, will be a “real head turner” for the electricity market when it launches in the next couple of months, and a boon to both renewable energy developers and big energy users.

The Hub’s parent company, TFS Green, has already successfully trialled a “firm solar contract” product, as RenewEconomy reported in 2018, which replicates the “shape” of solar generation, and then matches the buyer’s needs with contracts for supply to the wholesale market, thus guaranteeing a flat and fixed price for that power.

“It is de-risking and firming up solar generation for project owners and market participants,” Halliwell told RenewEconomy at the time.

But the scope of the fully-launched Renewable Energy Hub will extend well beyond solar and, says Halliwell, will be particularly well suited to “firming technologies” like battery storage.

“This effectively turns a financial firming solution into a physical firming solution, hastening the arrival of those storage and other balancing resources required to help the energy system make the required transition to 100 per cent renewables,” said Halliwell.

“It’s exactly what the market needs, beyond subsidies and beyond PPAs,” Halliwell told RE in an interview on Monday, as new reports emerge warning that the Coalition’s energy policy void could reverse the positive effects on the NEM of a massive roll-out of large-scale solar and wind.

Already, the lack of any longer-term renewable energy policy beyond the RET is believed to have been a bit player in a massive slump in investment in large-scale solar and wind in 2019, confirmed at 60 per cent below 2018 levels by BloombergNEF, and at a 50 per cent reduction by the Clean Energy Council.

“(The Renewable Energy Hub) will drive project finance and investment and unlock uptake of renewaables,” Halliwell said, allowing renewable energy developers to capture better pricing via contracts better suited to their technology type.

“It will also provide new incentives for market players to seek out assets – such as batteries and other ‘balancing’ resources – that can firm up the intermittency of renewables.”

On the other side of the market, Halliwell added, it will help meet the demands of a booming audience of corporate customers looking to transact energy in a different way.

Source: https://reneweconomy.com.au/new-trading-platform-aims-to-unlock-investment-in-renewables-big-batteries-92280/

Tags: , , , , ,
Posted in HPQ-Silicon Resources Inc. | Comments Off on New trading platform aims to unlock investment in #renewables, big #batteries SPONSOR: $HPQ.ca Silicon $FSLR $SPWR $CSIQ $PYR.ca $XMG.ca

#ZeU – Legacy Databases Applications Can Now Be #Blockchain Enabled $SX $SX.ca $SXOOF

Posted by AGORACOM-JC at 4:31 PM on Thursday, December 5th, 2019
  • ZeU Crypto Networks Inc., has filed a new provisional patent entitled “Method and System for Converting Database Applications into Blockchain Applications.”
  • The new IP provides a convenient method for combining traditional applications with blockchain technology.

Montreal – December 5, 2019 – St-Georges Eco-Mining Corp. (CNSX:SX.CN) (OTC:SXOOF) (FSE:85G1) is pleased to announce that its subsidiary, ZeU Crypto Networks Inc., has filed a new provisional patent entitled “Method and System for Converting Database Applications into Blockchain Applications.” The new IP provides a convenient method for combining traditional applications with blockchain technology.

This method does not require any modifications to existing applications. On the database layer, we directly ensure data in the database maintains synchronization with the data in the blockchain. Traditional enterprise applications are database-based applications, and all business services are built upon relational or non-relational databases. A common problem in the process of migrating from enterprise applications to blockchain applications is that the overall structure of blockchain is very different from traditional enterprise applications. Enterprise applications must be significantly modified or even rewritten to fit the structure of blockchain’s logic.

This patent provides a method and system for converting database-based applications into blockchain-based applications; multiple applications on different nodes can automatically perform global data consensus to prevent data conflicts. The basic method is to monitor the database written by applications, extract data operations from transaction logs, convert the data operations to a general format, and activate the smart contract on the blockchain to complete the data consensus check at multiple nodes. Each node monitors the blocks on blockchain and synchronizes the data back to the database. In the case of conflicting or illegal data, the data is not able to pass consensus and synchronize with the other nodes in the blockchain. The local nodes automatically roll back when detecting invalid data.

Example 1: Electrical Certificate

In this case, when a record is generated locally, and it needs to be retrieved later for confirmation, such as legal documents, bank orders, etc. Traditionally a centralized database has been used to store the data and validate the conflicts. With the method in this patent, traditional database-based apps could be easily converted to a blockchain-based decentralized system and expanded to multiple organizations.

In a traditional environment, all apps must be based on the same database to store and verify the data. With the method in this patent, there is no need to modify the app code, insert the BC-DB adapter layer between the database and the blockchain in each node, and then select the fields in the database to automatically synchronize to all other databases through the blockchain. If there is a data conflict, the adapter resolves it. All the changes from DB1 and DB3 are synchronized to DB2, and APP 2 could query all confirmed data.

Example 2: Supply Chain

For supply chain scenarios, there may be different participants, like part suppliers, manufacturers, logistic companies, retailers, banks, etc. Product info data needs to be shared between different organizations. Suppliers write records for parts supplied to the manufacturer. Manufacturers write product information and which parts were used for which product. Logistic companies write details regarding product transportation. Retailers write product sales information. The bank needs all the aforementioned information to issue loans.

By adding an adapter beside each database, the databases on different nodes could be synchronized and achieve impressive results. The supply company knows the inventory of the manufacturer. It thus could prepare parts in advance, thereby shortening the lead-time. The logistic company could get the product data even if it is still at the manufacturer, and can arrange vehicles in advance. The manufacturer receives the retail data to help plan the manufacturing cycle to better suit market needs. The bank could receive all the data from the different nodes to detect potential fraud and issue loans to participants.

St-Georges Eco-Mining Other Corporate Matters

Amended listing statement for ZeU

St-Georges subsidiary, ZeU Crypto Networks Inc, has filed today an amended listing statement with the Canadian Securities Exchange that takes into account the recent changes in short-term debt ratios that were previously holding the process. Management will keep its shareholders informed on the progress when material information becomes available.

Missing & Incorrect Information from Latest Press Release

St-Georges would like to correct a mistake include in the December 1, 2019 Press Release “Closing of First Tranche of Financing.” Some versions of the press release were disseminated with the wrong amount being raised. The total amount raised is $500,100, while the erroneous release mentioned $501,100. Additionally, one insider subscribing in the private placement was omitted from the list. Enrico Di Cesare, a director and insider of the company, subscribed to 300,000 units of the placement for a total of $30,000.

ON BEHALF OF THE BOARD OF DIRECTORS

“Frank Dumas”

FRANK DUMAS

DIRECTOR & COO, ST-GEORGES ECO-MINING

PRESIDENT & CEO, ZEU CRYPTO NETWORKS.

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

Copyright (c) 2019 TheNewswire – All rights reserved.

Tags: , , , , ,
Posted in St Georges Eco-Mining Technologies | Comments Off on #ZeU – Legacy Databases Applications Can Now Be #Blockchain Enabled $SX $SX.ca $SXOOF

INTERVIEW: PyroGenesis $PYR.ca Numbers Speak For Themselves; $29.5M Backlog + $13.5M Aircraft Carrier Contract Imminent $LMT $RTN $NOC $UTX $HPQ.ca $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 10:28 AM on Wednesday, December 4th, 2019

“These results signal the beginning of the long-awaited breakout that we have been anticipating…’  These are the words of PyroGenesis CEO, Peter Pascali, and they are backed up by Q3 results that included a 91% increases in revenue and a 492% increase in signed contracts that are now in backlog to the tune of $29.5M, thanks to a monster contract win in October.  

If that wasn’t enough, after already having sold two plasma torch based systems to the US Navy for installation on two aircraft carries, the Company has already been advised by the US Navy that 2 more orders are coming for two more aircraft carriers to the tune of $13.5M.  

Even the Head of TSX Venture noticed the results on Linkedin recently:  

If you are just discovering PyroGenesis (PYR:TSXV) then grab your favourite drink and watch this powerful video …. or listen in via podcast when you want to tune out the world and learn about an incredible company.

Tags: , , , , , , ,
Posted in AGORACOM Via Satellite, Featured, PyroGenesis Canada Inc. | Comments Off on INTERVIEW: PyroGenesis $PYR.ca Numbers Speak For Themselves; $29.5M Backlog + $13.5M Aircraft Carrier Contract Imminent $LMT $RTN $NOC $UTX $HPQ.ca $DDD.ca $SSYS $PRLB

« Older Entries
Newer Entries »